DelveInsight Blogs Sitemap

All Posts in this category
S.No. Product Name Actions
1 Aelis Farma pockets $30M; Alcyone unveils $23M for AAV gene therapies; Progentec and GSK collaborate; Kozin bags $60M Visit Post
2 Pharma Companies Foray into the ABSSSI Market to Develop Novel Antibiotics and Tackle Antibiotic Resistance Visit Post
3 Vertex leads in CRISPR Therapeutics deal; Update for Phase 2 clinical trial of KVD824; Ovid dumps lead program; Virta Health pulls in $133M Visit Post
4 Merck, Gilead teams up for HIV treatment; Bright Future for Sanofi/Regeneron’s Libtayo; Roche acquires GenMark; FDA okays Melinta's Kimyrsa Visit Post
5 Beam makes USD 120M bet; GRAIL and Quest announce the collaboration; Brain organoids mimic infant’s brains; Improvement in T cells to kill cancer Visit Post
6 Plaque psoriasis drug outshines in phase III trial; Immunovant announces pause in trial of IMVT-1401; Prothena brings AL amyloidosis drug back; Canon Medical expands its MRI AI programs Visit Post
7 Horizon, Viela Deal; Concert Schizo Drug Flop; Gilead Deals with Arcus and Gritstone Visit Post
8 A Need for Curative Treatment Expected to Attract the Pharma Players in the Hallux Valgus Market Landscape Visit Post
9 Bristol Myers' psoriasis drug; GW Pharmaceuticals eyes US market for Nabiximols; Karyopharm's Xpovio; Kiadis USD 358M Buyout Visit Post
10 Pharma Players Line Up To Launch Novel Therapies Fueling Epidermolysis Bullosa Market Size Visit Post
11 Do We Have A Cure For Rosacea? Visit Post
12 Incyte meets endpoint in second atopic dermatitis trial; NeoTX lands USD 45 M series C; Five Prime Therapeutics’ pancreatic cancer a bust Visit Post
13 Thumbs down to NKTR-181, Lilly expands its insulin armamentarium Visit Post
14 Chronic Hand Eczema Market Analysis and Forecast Visit Post
15 Atopic dermatitis market and a Dupilumab dominance Visit Post
16 Atopic dermatitis market: Increasing prevalence and topical treatments Visit Post
17 World Psoriasis Day Visit Post
18 AngioDynamics acquires Eximo; MiroBio raises USD 33 M; Janssen submits sBLA for Stelara Visit Post
19 Psoriasis Pipeline: Upcoming Psoriasis Treatments Visit Post
20 Psoriasis Therapy Market Size  Visit Post
21 Generalized Pustular Psoriasis Market Visit Post
22 Acne Vulgaris Market Outlook Visit Post
23 Acute Bacterial Skin and Skin Structure Infections Emerging Therapies Visit Post
24 ABSSSI Current Therapeutic Market Visit Post
25 Recent Market Reports Visit Post
26 Peloton raises $150M; BiomX raises $32M; Abbott and Novo collaborate; Blaze Bioscience nets $5M Visit Post
27 Actinic Keratosis – A Warning Sign for Potential Skin Cancer Visit Post
28 Notizia Visit Post
29 Biologic Parallel – A Perky Future Ahead Visit Post
30 Notizia Visit Post
31 Idera's drug; CRISPR increase risk; Juvenescence grabbed USD 50M; AstraZeneca, Lilly terminates Visit Post
32 Business Cocktail Visit Post
33 NOTIZIA Visit Post
34 Business Cocktail Visit Post
35 Biohaven’s trial ; GSK integrates; FDA Approval; Phase III trial Visit Post
36 Actinic Keratosis – A Warning Sign for Potential Skin Cancer Visit Post
37 Vitiligo – High Unmet Need Indeed! Visit Post
38 Cancer, diabetes and eczema on list; AbbVie's Humira; Teva weighs $2B; Fresenius in buyout talks Visit Post
39 FDA grants approval; Sanaria receives fast-track designation; Sanofi and Regeneron’s next blockbuster; Allele receives NIH grant Visit Post
40 AstraZeneca’s new Asthma Drug Aces Phase III trial Visit Post
41 LAG-3 Antagonists, TIM-3 Antagonists; OX40 Agonists- Pipeline Insights, 2016 - A DelveInsight Report Visit Post
42 DelveInsight’s Dermatology based Gene Therapy Reports Visit Post